D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 83 Citations 38,631 201 World Ranking 8225 National Ranking 4485

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Internal medicine
  • Gene

Internal medicine, Cervical intraepithelial neoplasia, Cervical cancer, Immunology and Gynecology are her primary areas of study. Cosette M. Wheeler combines subjects such as Vaccine efficacy and Vaccination with her study of Internal medicine. Her work carried out in the field of Cervical intraepithelial neoplasia brings together such families of science as Oncology, Colposcopy, Relative risk, Papillomaviridae and HPV vaccines.

Her Cervical cancer research is multidisciplinary, relying on both Carcinoma in situ and Virus. Her Immunology research incorporates themes from Genital warts, Carcinoma and HLA-DQ Antigen. Cosette M. Wheeler has included themes like Placebo, Epidemiology and Human papillomavirus in her Gynecology study.

Her most cited work include:

  • Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (1540 citations)
  • Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial (1474 citations)
  • Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial (1374 citations)

What are the main themes of her work throughout her whole career to date?

Cosette M. Wheeler mainly investigates Cervical intraepithelial neoplasia, Cervical cancer, Internal medicine, Gynecology and Papillomaviridae. Her biological study spans a wide range of topics, including Cervical screening, Cytology, Colposcopy and Vaccination. In Cervical cancer, Cosette M. Wheeler works on issues like Immunology, which are connected to Haplotype.

Her Internal medicine study combines topics in areas such as Oncology and Vaccine efficacy. Her research integrates issues of Odds ratio, Epidemiology, Cervix, Obstetrics and Risk factor in her study of Gynecology. Her studies deal with areas such as Viral Vaccine, Genotype and Virology as well as Papillomaviridae.

She most often published in these fields:

  • Cervical intraepithelial neoplasia (39.17%)
  • Cervical cancer (34.58%)
  • Internal medicine (35.42%)

What were the highlights of her more recent work (between 2014-2021)?

  • Cervical intraepithelial neoplasia (39.17%)
  • Cervical cancer (34.58%)
  • Internal medicine (35.42%)

In recent papers she was focusing on the following fields of study:

Her main research concerns Cervical intraepithelial neoplasia, Cervical cancer, Internal medicine, Gynecology and Vaccination. Her work deals with themes such as Young adult, Papillomaviridae, Cervical screening, Cytology and Obstetrics, which intersect with Cervical intraepithelial neoplasia. Her Internal medicine study combines topics from a wide range of disciplines, such as Oncology and Vaccine efficacy.

The concepts of her Gynecology study are interwoven with issues in Human papillomavirus and Mass screening. Her Vaccination research includes themes of Clinical trial, Incidence, Randomized controlled trial, HPV infection and Cohort. Her HPV infection study incorporates themes from Squamous intraepithelial lesion and Immunology.

Between 2014 and 2021, her most popular works were:

  • Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes : updated systematic review and meta-analysis (207 citations)
  • Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials (194 citations)
  • Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study (82 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Cosette M. Wheeler mainly investigates Cervical intraepithelial neoplasia, Internal medicine, Cervical cancer, Papillomaviridae and Young adult. Her Cervical intraepithelial neoplasia research is multidisciplinary, incorporating elements of Gynecology, HPV infection and Vaccination. She has researched Vaccination in several fields, including Incidence, HPV vaccines and Cohort.

Her research in Internal medicine is mostly concerned with Cancer. Her research in Cervical cancer intersects with topics in Family medicine and Biostatistics. Her Papillomaviridae research is multidisciplinary, incorporating perspectives in Cytology, Genotyping Techniques and Genotype.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Suzanne M. Garland;Suzanne M. Garland;Mauricio Hernandez-Avila;Cosette M. Wheeler;Gonzalo Perez.
The New England Journal of Medicine (2007)

2238 Citations

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Diane M. Harper;Eduardo L. Franco;Cosette Wheeler;Daron Gale Ferris.
The Lancet (2004)

2220 Citations

A controlled trial of a human papillomavirus type 16 vaccine.

Laura A. Koutsky;Kevin A. Ault;Cosette M. Wheeler;Darron R. Brown.
The New England Journal of Medicine (2002)

2201 Citations

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler.
The Lancet (2009)

2128 Citations

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Diane M Harper;Eduardo L Franco;Cosette M Wheeler;Anna-Barbara Moscicki.
The Lancet (2006)

2105 Citations

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta;Rosires P. Andrade.
Lancet Oncology (2005)

1902 Citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud.
The Lancet (2007)

1784 Citations

Improved Amplification of Genital Human Papillomaviruses

P. E. Gravitt;C. L. Peyton;T. Q. Alessi;C. M. Wheeler.
Journal of Clinical Microbiology (2000)

1328 Citations

Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method

P. E. Gravitt;C. L. Peyton;R. J. Apple;C. M. Wheeler.
Journal of Clinical Microbiology (1998)

784 Citations

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn.
Lancet Oncology (2012)

781 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Cosette M. Wheeler

Mark Schiffman

Mark Schiffman

National Institutes of Health

Publications: 222

Joakim Dillner

Joakim Dillner

Karolinska University Hospital

Publications: 195

Suzanne M. Garland

Suzanne M. Garland

Royal Women's Hospital

Publications: 193

Eduardo L. Franco

Eduardo L. Franco

McGill University

Publications: 193

Luisa L. Villa

Luisa L. Villa

Universidade de São Paulo

Publications: 173

Anna R. Giuliano

Anna R. Giuliano

University of South Florida

Publications: 154

Chris J.L.M. Meijer

Chris J.L.M. Meijer

Vrije Universiteit Amsterdam

Publications: 138

Patti E. Gravitt

Patti E. Gravitt

George Washington University

Publications: 136

Rolando Herrero

Rolando Herrero

International Agency For Research On Cancer

Publications: 125

Robert D. Burk

Robert D. Burk

Albert Einstein College of Medicine

Publications: 123

Allan Hildesheim

Allan Hildesheim

National Institutes of Health

Publications: 120

John T. Schiller

John T. Schiller

National Institutes of Health

Publications: 118

François Coutlée

François Coutlée

University of Montreal

Publications: 117

Matti Lehtinen

Matti Lehtinen

Karolinska Institute

Publications: 110

Wim Quint

Wim Quint

Erasmus University Rotterdam

Publications: 107

Silvia Franceschi

Silvia Franceschi

Centro di Riferimento Oncologico

Publications: 105

Trending Scientists

Igor L. Markov

Igor L. Markov

Facebook (United States)

Michael R. Baye

Michael R. Baye

Indiana University

Wuhua Li

Wuhua Li

Zhejiang University

Dan Botez

Dan Botez

University of Wisconsin–Madison

François Nicot

François Nicot

Grenoble Alpes University

Deepankar Choudhury

Deepankar Choudhury

Indian Institute of Technology Bombay

Rajasekhar Balasubramanian

Rajasekhar Balasubramanian

National University of Singapore

Luigi G. Marzilli

Luigi G. Marzilli

Louisiana State University

Nigam P. Rath

Nigam P. Rath

University of Missouri–St. Louis

Elisabete Moreira Assaf

Elisabete Moreira Assaf

Universidade de São Paulo

Yiping Zhao

Yiping Zhao

University of Georgia

Nicolas Gross

Nicolas Gross

University of Clermont Auvergne

Sydney Kustu

Sydney Kustu

University of California, Berkeley

Clare L. Cutland

Clare L. Cutland

University of the Witwatersrand

Timothy E. Wilens

Timothy E. Wilens

Harvard University

Pekka Collin

Pekka Collin

Tampere University

Something went wrong. Please try again later.